Product Code: ETC066989 | Publication Date: Aug 2021 | Updated Date: Aug 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 France Non-Oncology Precision Medicine Market Overview |
3.1 France Country Macro Economic Indicators |
3.2 France Non-Oncology Precision Medicine Market Revenues & Volume, 2021 & 2031F |
3.3 France Non-Oncology Precision Medicine Market - Industry Life Cycle |
3.4 France Non-Oncology Precision Medicine Market - Porter's Five Forces |
3.5 France Non-Oncology Precision Medicine Market Revenues & Volume Share, By Form, 2021 & 2031F |
3.6 France Non-Oncology Precision Medicine Market Revenues & Volume Share, By Ecosystem, 2021 & 2031F |
4 France Non-Oncology Precision Medicine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing adoption of personalized medicine in the healthcare industry |
4.2.2 Technological advancements in genomics and molecular diagnostics |
4.2.3 Growing awareness about the benefits of precision medicine in non-oncology treatments |
4.3 Market Restraints |
4.3.1 High cost associated with precision medicine technologies and treatments |
4.3.2 Regulatory challenges and reimbursement issues |
4.3.3 Limited availability of skilled professionals in precision medicine |
5 France Non-Oncology Precision Medicine Market Trends |
6 France Non-Oncology Precision Medicine Market, By Types |
6.1 France Non-Oncology Precision Medicine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 France Non-Oncology Precision Medicine Market Revenues & Volume, By Application, 2018 - 2027F |
6.1.3 France Non-Oncology Precision Medicine Market Revenues & Volume, By Neurology, 2018 - 2027F |
6.1.4 France Non-Oncology Precision Medicine Market Revenues & Volume, By Endocrinology, 2018 - 2027F |
6.1.5 France Non-Oncology Precision Medicine Market Revenues & Volume, By Life Sciences, 2018 - 2027F |
6.1.6 France Non-Oncology Precision Medicine Market Revenues & Volume, By Cardiovascular, 2018 - 2027F |
6.1.7 France Non-Oncology Precision Medicine Market Revenues & Volume, By Others, 2018 - 2027F |
6.2 France Non-Oncology Precision Medicine Market, By Ecosystem |
6.2.1 Overview and Analysis |
6.2.2 France Non-Oncology Precision Medicine Market Revenues & Volume, By Precision Diagnostics, 2018 - 2027F |
6.2.3 France Non-Oncology Precision Medicine Market Revenues & Volume, By Digital Health and Information Technology, 2018 - 2027F |
6.2.4 France Non-Oncology Precision Medicine Market Revenues & Volume, By Applied Sciences, 2018 - 2027F |
7 France Non-Oncology Precision Medicine Market Import-Export Trade Statistics |
7.1 France Non-Oncology Precision Medicine Market Export to Major Countries |
7.2 France Non-Oncology Precision Medicine Market Imports from Major Countries |
8 France Non-Oncology Precision Medicine Market Key Performance Indicators |
8.1 Number of clinical trials incorporating precision medicine in non-oncology treatments |
8.2 Adoption rate of precision medicine tools and technologies by healthcare providers |
8.3 Patient outcomes and improvements in treatment efficacy with precision medicine interventions |
8.4 Investment in research and development of precision medicine solutions |
8.5 Collaboration and partnerships between pharmaceutical companies and research institutions in the field of non-oncology precision medicine |
9 France Non-Oncology Precision Medicine Market - Opportunity Assessment |
9.1 France Non-Oncology Precision Medicine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 France Non-Oncology Precision Medicine Market Opportunity Assessment, By Ecosystem, 2021 & 2031F |
10 France Non-Oncology Precision Medicine Market - Competitive Landscape |
10.1 France Non-Oncology Precision Medicine Market Revenue Share, By Companies, 2021 |
10.2 France Non-Oncology Precision Medicine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |